Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Mga view
• 07/09/23
0
0
I-embed
administrator
Mga subscriber
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento